Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the effect of pioglitazone treatment on insulin
secretion, insulin resistance, and progression of atherosclerosis in renal allograft
recipients without preoperative history of diabetes.